Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population. [electronic resource]
Producer: 20090810Description: 863-9 p. digitalISSN:- 1432-0584
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols
- Cyclophosphamide -- therapeutic use
- Disease-Free Survival
- Doxorubicin -- therapeutic use
- Female
- Humans
- Lymphoma, Large B-Cell, Diffuse -- diagnosis
- Male
- Middle Aged
- Prednisone -- therapeutic use
- Prognosis
- Rituximab
- Vincristine -- therapeutic use
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.